November 2019
Volume 14 Issue 11 |
|
|
|
|
Features
Using automation and taking a step-by-step approach can facilitate the process of selecting a top-quality cell-line source.
/ read more /
Industry experts examine the fundamentals of dissolution testing, including challenges resulting from an increasing number of poorly soluble molecules under development in the pharmaceutical pipeline.
/ read more /
|
|
|
Subscribe
Subscribers can enjoy each full issue of Pharmaceutical Technology in print or via the PharmTech app.
subscription offers |
 |
|
|
|
News
Waters will join several venture investors including, Floodgate Capital, First Round Capital, Underscore VC, Founder Collective, and Y Combinator, to invest in TetraScience’s $8-million series A round of financing.
/ read more /
The company is expanding its bioanalytical capacity and capabilities to support biologic drug development, cell and gene therapy development, and biomarker analysis.
/ read more /
The new services provide rapid production of antibody drug conjugates (ADCs) for best candidate selection.
/ read more /
The companies agreed to a multi-year research and development collaboration that will focus on AI empowerment and exploration.
/ read more /
The new incubators are set to be operational starting in 2021.
/ read more /
|
|
|
New Technology
In response to customer requests for a more secure closure, the company equipped the new lab coat with a nylon zipper and no-pocket design, rather than the typical snap design, which runs the risk of contamination to people and processes.
/ read more /
The new device is a modular system made to integrate into isolators or RABS, using an external controller and remotely located air mover.
/ read more /
The new device guarantees high accuracy code reading through an anti-frost system and a deep-focus image sensor.
/ read more /
Clear Advantage is a product line of multichannel reagent reservoirs to be used for creating a next-gen sequencing library
/ read more /
|
|
|
|
|
